FindTrial
Sign In

A Correlative Study on Receptor-Related Signaling Pathways in Esophagogastric Junction Cancer

A Correlative Study on Receptor-Related Signaling Pathways in Esophagogastric Junction Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108387
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-20
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagogastric Junction Adenocarcinoma

Interventions

Esophagogastric junction adenocarcinoma group:None

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.The patient has undergone surgical resection; 2.Pathologically confirmed as esophagogastric junction adenocarcinoma; 3.Complete clinical and follow-up data; 4.Age is greater than 18 and less than or equal to 85;

Exclusion criteria

Exclusion criteria: 1.Concomitant with other malignant tumors; 2.With severe comorbidities; 3.Secondary resection for tumor recurrence; 4.Received antitumor therapy before surgery;

Design outcomes

Primary

MeasureTime frame
Overall Survival (OS);—

Secondary

MeasureTime frame
Disease-free survival (DFS);—

Countries

China

Contacts

Public ContactChu Dake

The First Affiliated Hospital of Xi'an Jiaotong University

chudake@xjtu.edu.cn+86 13720405103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026